Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breas...

por Berg, Tobias, Jensen, Maj-Britt, Jakobsen, Erik H., Al-Rawi, Sami, Kenholm, Julia, Andersson, Michael
Publicado 2020